Elapegademase

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameElapegademase
Drug Alias NamePegylated recombinant adenosine deaminasePegademase recombinantPolyethylene glycol recombinant adenosine deaminaseElapegademase-lvlrRevcovi +[8] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAdenosine deaminase replacements
TargetsAdenosine
Therapy Area/IndicationsAdenosine deaminase deficiencySevere Combined Immunodeficiency
Global Approved IndicationsAdenosine deaminase deficiencySevere Combined Immunodeficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/10/05
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLeadiant Biosci
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Usa IncTeijin Pharma Ltd
Inactive CompaniesLeadiant Biosciences Inc
Active IndicationsAdenosine deaminase deficiencySevere Combined Immunodeficiency
Inactive IndicationsN/A

Other Information

ATC CodeL03AX21
Related LinksKEGG